Panel Discussion: Evolving the Patient Engagement Paradigm in Rare Disease

Time: 4:00 pm
day: Day Two PM


  • Outlining how all stakeholders stand to benefit from patient groups being involved throughout the drug development path
  • How can drug developers ensure that the patient voice is never lost throughout the development process?
  • Where in the drug development pathway are their further opportunities for drug developers to engage rare disease patient groups?
  • Stories of successful patient engagement and potential areas for industry to improve on